These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 32665022)
1. Molecular and clinicopathologic features of gliomas harboring NTRK fusions. Torre M; Vasudevaraja V; Serrano J; DeLorenzo M; Malinowski S; Blandin AF; Pages M; Ligon AH; Dong F; Meredith DM; Nasrallah MP; Horbinski C; Dahiya S; Ligon KL; Santi M; Ramkissoon SH; Filbin MG; Snuderl M; Alexandrescu S Acta Neuropathol Commun; 2020 Jul; 8(1):107. PubMed ID: 32665022 [TBL] [Abstract][Full Text] [Related]
2. NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors. Kim EE; Park CK; Kim SK; Phi JH; Paek SH; Choi JY; Kang HJ; Lee JH; Won JK; Yun H; Park SH Acta Neuropathol Commun; 2024 Jul; 12(1):118. PubMed ID: 39014476 [TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of cancers with NTRK gene fusions. Gatalica Z; Xiu J; Swensen J; Vranic S Mod Pathol; 2019 Jan; 32(1):147-153. PubMed ID: 30171197 [TBL] [Abstract][Full Text] [Related]
4. Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population. Zhao R; Yao F; Xiang C; Zhao J; Shang Z; Guo L; Ding W; Ma S; Yu A; Shao J; Zhu L; Han Y J Pathol Clin Res; 2021 Jul; 7(4):375-384. PubMed ID: 33768710 [TBL] [Abstract][Full Text] [Related]
5. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing. Bourhis A; Caumont C; Quintin-Roué I; Magro E; Dissaux G; Remoué A; Le Noac'h P; Douet-Guilbert N; Seizeur R; Tyulyandina A; Schick U; Merlio JP; Marcorelles P; Cappellen D; Uguen A Pathology; 2022 Feb; 54(1):55-62. PubMed ID: 34518039 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in Japan. Nakata E; Osone T; Ogawa T; Taguchi T; Hattori K; Kohsaka S Cancer Med; 2024 Jun; 13(12):e7351. PubMed ID: 38925616 [TBL] [Abstract][Full Text] [Related]
7. Long-Term Tumor Stability After First-Line Treatment With Larotrectinib in an Infant With NTRK2 Fusion-Positive High-Grade Glioma. Simoneau J; Robertson P; Muraszko K; Maher CO; Garton H; Calvert R; Koschmann C; Upadhyaya SA; Mody R; Brown N; Kumar-Sinha C; Parmar H; Camelo-Piragua S; Franson AT J Natl Compr Canc Netw; 2024 Sep; 22(7):. PubMed ID: 39236755 [TBL] [Abstract][Full Text] [Related]
8. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact. Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238 [TBL] [Abstract][Full Text] [Related]
9. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591 [TBL] [Abstract][Full Text] [Related]
10. Jones KA; Bossler AD; Bellizzi AM; Snow AN Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936198 [TBL] [Abstract][Full Text] [Related]
11. Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland. Zhang W; Schmitz AA; Kallionpää RE; Perälä M; Pitkänen N; Tukiainen M; Alanne E; Jöhrens K; Schulze-Rath R; Farahmand B; Zong J Acta Oncol; 2024 Jul; 63():542-551. PubMed ID: 38967220 [TBL] [Abstract][Full Text] [Related]
13. Glioblastomas harboring gene fusions detected by next-generation sequencing. Woo HY; Na K; Yoo J; Chang JH; Park YN; Shim HS; Kim SH Brain Tumor Pathol; 2020 Oct; 37(4):136-144. PubMed ID: 32761533 [TBL] [Abstract][Full Text] [Related]
14. Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents. Roa P; Foglizzo V; Harada G; Repetto M; Kulick A; de Stanchina E; de Marchena M; Auwardt S; Sayed Ahmed S; Bremer NV; Yang SR; Feng Y; Zhou C; Kong N; Liang R; Xu H; Zhang B; Bardelli A; Toska E; Ventura A; Drilon A; Cocco E Br J Cancer; 2024 Aug; 131(3):601-610. PubMed ID: 38902532 [TBL] [Abstract][Full Text] [Related]
15. A novel PTPRZ1-ETV1 fusion in gliomas. Matjašič A; Zupan A; Boštjančič E; Pižem J; Popović M; Kolenc D Brain Pathol; 2020 Mar; 30(2):226-234. PubMed ID: 31381204 [TBL] [Abstract][Full Text] [Related]
16. The Diagnostic Value of Pan-Trk Expression to Detect Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion in CNS Tumours: A Study Using Next-Generation Sequencing Platform. Mohamed F; Kurdi M; Baeesa S; Sabbagh AJ; Hakamy S; Maghrabi Y; Alshedokhi M; Dallol A; Halawa TF; Najjar AA; Fdl-Elmula I Pathol Oncol Res; 2022; 28():1610233. PubMed ID: 35295612 [No Abstract] [Full Text] [Related]
17. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients. Meredith DM; Cooley LD; Dubuc A; Morrissette J; Sussman RT; Nasrallah MP; Rathbun P; Yap KL; Wadhwani N; Bao L; Wolff DJ; Ida C; Sukhanova M; Horbinski C; Jennings LJ; Farooqi M; Gener M; Ginn K; Kam KL; Sasaki K; Kanagal-Shamanna R; Alexandrescu S; Brat D; Lu X Mod Pathol; 2023 Nov; 36(11):100294. PubMed ID: 37532182 [TBL] [Abstract][Full Text] [Related]
18. Recurrent Khuong-Quang DA; Brown LM; Wong M; Mayoh C; Sexton-Oates A; Kumar A; Pinese M; Nagabushan S; Lau L; Ludlow LE; Gifford AJ; Rodriguez M; Desai J; Fox SB; Haber M; Ziegler DS; Hansford JR; Marshall GM; Cowley MJ; Ekert PG Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33144287 [TBL] [Abstract][Full Text] [Related]
19. The landscape of cancer-associated transcript fusions in adult brain tumors: a longitudinal assessment in 140 patients with cerebral gliomas and brain metastases. Metellus P; Camilla C; Bialecki E; Beaufils N; Vellutini C; Pellegrino E; Tomasini P; Ahluwalia MS; Mansouri A; Nanni I; Ouafik L Front Oncol; 2024; 14():1382394. PubMed ID: 39087020 [TBL] [Abstract][Full Text] [Related]